These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32158755)
1. Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy. Amato R; Giannaccini M; Dal Monte M; Cammalleri M; Pini A; Raffa V; Lulli M; Casini G Front Bioeng Biotechnol; 2020; 8():144. PubMed ID: 32158755 [TBL] [Abstract][Full Text] [Related]
2. VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy. Amato R; Biagioni M; Cammalleri M; Dal Monte M; Casini G Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3066-76. PubMed ID: 27286364 [TBL] [Abstract][Full Text] [Related]
3. Autophagy-mediated neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy. Amato R; Catalani E; Dal Monte M; Cammalleri M; Di Renzo I; Perrotta C; Cervia D; Casini G Pharmacol Res; 2018 Feb; 128():167-178. PubMed ID: 28970178 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: Evaluation of the surface properties and effect on their distribution. Apaolaza PS; Busch M; Asin-Prieto E; Peynshaert K; Rathod R; Remaut K; Dünker N; Göpferich A Exp Eye Res; 2020 Sep; 198():108151. PubMed ID: 32721426 [TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy. Amato R; Dal Monte M; Lulli M; Raffa V; Casini G Curr Neuropharmacol; 2018; 16(7):993-1003. PubMed ID: 28714394 [TBL] [Abstract][Full Text] [Related]
6. Magnetic nanoparticles as intraocular drug delivery system to target retinal pigmented epithelium (RPE). Giannaccini M; Giannini M; Calatayud MP; Goya GF; Cuschieri A; Dente L; Raffa V Int J Mol Sci; 2014 Jan; 15(1):1590-605. PubMed ID: 24451140 [TBL] [Abstract][Full Text] [Related]
7. Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Prow TW; Bhutto I; Kim SY; Grebe R; Merges C; McLeod DS; Uno K; Mennon M; Rodriguez L; Leong K; Lutty GA Nanomedicine; 2008 Dec; 4(4):340-9. PubMed ID: 18640079 [TBL] [Abstract][Full Text] [Related]
8. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats. Mahaling B; Srinivasarao DA; Raghu G; Kasam RK; Bhanuprakash Reddy G; Katti DS Nanoscale; 2018 Sep; 10(35):16485-16498. PubMed ID: 29897081 [TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421 [TBL] [Abstract][Full Text] [Related]
10. Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model. Becker S; Wang H; Stoddard GJ; Hartnett ME Mol Vis; 2017; 23():832-843. PubMed ID: 29259390 [TBL] [Abstract][Full Text] [Related]
12. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy. Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793 [TBL] [Abstract][Full Text] [Related]
13. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Jiang S; Chen X Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of the neuropeptides PACAP, substance P and the somatostatin analogue octreotide in retinal ischemia: a metabolomic analysis. D'Alessandro A; Cervia D; Catalani E; Gevi F; Zolla L; Casini G Mol Biosyst; 2014 Jun; 10(6):1290-304. PubMed ID: 24514073 [TBL] [Abstract][Full Text] [Related]
16. Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye. Giannaccini M; Pedicini L; De Matienzo G; Chiellini F; Dente L; Raffa V Sci Rep; 2017 Mar; 7():43092. PubMed ID: 28256525 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin replacement: a new strategy for treating diabetic retinopathy. Hernández C; Simó R; Curr Med Chem; 2013; 20(26):3251-7. PubMed ID: 23745546 [TBL] [Abstract][Full Text] [Related]
18. Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye. Xu L; Xu X; Chen H; Li X Colloids Surf B Biointerfaces; 2013 Dec; 112():30-4. PubMed ID: 23939422 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin. Cervia D; Catalani E; Dal Monte M; Casini G J Neurochem; 2012 Mar; 120(5):818-29. PubMed ID: 22168912 [TBL] [Abstract][Full Text] [Related]
20. Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopy. Schlichtenbrede FC; Mittmann W; Rensch F; Vom Hagen F; Jonas JB; Euler T Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5880-7. PubMed ID: 19578025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]